Insulin Glargine Controversy: A Tribute to the Editorial Team at Diabetologia

Por Butler, Peter C.
Publicado em 2009

Farewell Statement From Dr. Peter Butler as Outgoing Editor in Chief of Diabetes

Por Butler, Peter C.
Publicado em 2011

Glucagon-Like Peptide 1 Drugs as Second-Line Therapy for Type 2 Diabetes

Por Butler, Peter C.
Publicado no JAMA Intern Med (2016)

Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?

Por Costes, Safia, Butler, Peter C.
Publicado em 2014

GLP-1–Based Therapy for Diabetes: What You Do Not Know Can Hurt You

Por Butler, Peter C., Dry, Sarah, Elashoff, Robert
Publicado em 2010

Evaluation of immunohistochemical staining for glucagon in human pancreatic tissue

Por Gurlo, Tatyana, Butler, Peter C., Butler, Alexandra E.
Publicado no J Histotechnol (2016)

Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein

Por Matveyenko, Aleksey V., Veldhuis, Johannes D., Butler, Peter C.
Publicado em 2008

Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats

Por Matveyenko, Aleksey V., Veldhuis, Johannes D., Butler, Peter C.
Publicado em 2008

Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes

Por Satin, Leslie S., Butler, Peter C., Ha, Joon, Sherman, Arthur S.
Publicado no Mol Aspects Med (2015)

Many Commercially Available Antibodies for Detection of CHOP Expression as a Marker of Endoplasmic Reticulum Stress Fail Specificity Evaluation

Por Haataja, Leena, Gurlo, Tatyana, Huang, Chang-jiang, Butler, Peter C.
Publicado em 2008

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

Por Haataja, Leena, Gurlo, Tatyana, Huang, Chang J., Butler, Peter C.
Publicado em 2008

Response to Comment on: Saisho et al. β-Cell Mass and Turnover in Humans: Effects of Obesity and Aging. Diabetes Care 2013;36:111–117

Por Saisho, Yoshifumi, Butler, Alexandra E., Manesso, Erica, Butler, Peter C.
Publicado em 2013

Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats

Por Matveyenko, Aleksey V., Georgia, Senta, Bhushan, Anil, Butler, Peter C.
Publicado em 2010

UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: Evidence of interplay between the ubiquitin/proteasome system and autophagy

Por Costes, Safia, Gurlo, Tatyana, Rivera, Jacqueline F, Butler, Peter C
Publicado em 2014

Type 2 Diabetes as a Protein Misfolding Disease

Por Mukherjee, Abhisek, Morales-Scheihing, Diego, Butler, Peter C., Soto, Claudio
Publicado no Trends Mol Med (2015)

Increased Proliferation of the Pancreatic Duct Gland Compartment in Type 1 Diabetes

Por Moin, Abu Saleh Md, Butler, Peter C., Butler, Alexandra E.
Publicado no J Clin Endocrinol Metab (2016)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?

Por Butler, Peter C., Elashoff, Michael, Elashoff, Robert, Gale, Edwin A.M.
Publicado em 2013

Down Syndrome-Associated Diabetes Is Not Due To a Congenital Deficiency in β Cells

Por Butler, Alexandra E., Sacks, Wendy, Rizza, Robert A., Butler, Peter C.
Publicado no J Endocr Soc (2017)

Cyclin-Dependent Kinase 5 Promotes Pancreatic β-Cell Survival via Fak-Akt Signaling Pathways

Por Daval, Marie, Gurlo, Tatyana, Costes, Safia, Huang, Chang-jiang, Butler, Peter C.
Publicado em 2011

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?

Por Costes, Safia, Langen, Ralf, Gurlo, Tatyana, Matveyenko, Aleksey V., Butler, Peter C.
Publicado em 2013